|
1
|
Chabner BA and Roberts TG Jr: Timeline:
Chemotherapy and the war on cancer. Nat Rev Cancer. 5:65–72. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Gibalová L, Sereš M, Rusnák A, Ditte P,
Labudová M, Uhrík B, Pastorek J, Sedlák J, Breier A and Sulová Z:
P-glycoprotein depresses cisplatin sensitivity in L1210 cells by
inhibiting cisplatin-induced caspase-3 activation. Toxicol In
Vitro. 26:435–444. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mahon KL, Henshall SM, Sutherland RL and
Horvath LG: Pathways of chemotherapy resistance in
castration-resistant prostate cancer. Endocr Relat Cancer.
18:R103–R123. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Qu B, Aho KS, Li C, Kang S, Sillanpää M,
Yan F and Raymond PA: Greenhouse gases emissions in rivers of the
Tibetan Plateau. Sci Rep. 7:165732017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Goncharuk VV, Kavitskaya AA, Romanyukina
IY and Loboda OA: Revealing water's secrets: Deuterium depleted
water. Chem Cent J. 7:1032013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kushner DJ, Baker A and Dunstall TG:
Pharmacological uses and perspectives of heavy water and deuterated
compounds. Can J Physiol Pharmacol. 77:79–88. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Basov AA, Bykov IM, Baryshev MG, Dzhimak
SS and Bykov MI: Determination of deuterium concentration in foods
and influence of water with modified isotopic composition on
oxidation parameters and heavy hydrogen isotopes content in
experimental animals. Vopr Pitan. 83:43–50. 2014.(In Russian).
PubMed/NCBI
|
|
8
|
Rehakova R, Klimentova J, Cebova M, Barta
A, Matuskova Z, Labas P and Pechanova O: Effect of
deuterium-depleted water on selected cardiometabolic parameters in
fructose-treated rats. Physiol Res. 65 Supplementum 3:S401–S407.
2016.PubMed/NCBI
|
|
9
|
Cong FS, Zhang YR, Sheng HC, Ao ZH, Zhang
SY and Wang JY: Deuterium-depleted water inhibits human lung
carcinoma cell growth by apoptosis. Exp Ther Med. 1:277–283. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Gyöngyi Z, Budán F, Szabó I, Ember I, Kiss
I, Krempels K, Somlyai I and Somlyai G: Deuterium depleted water
effects on survival of lung cancer patients and expression of Kras,
Bcl2, and Myc genes in mouse lung. Nutr Cancer. 65:240–246. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hartmann J, Bader Y, Horvath Z, Saiko P,
Grusch M, Illmer C, Madlener S, Fritzer-Szekeres M, Heller N, Alken
RG and Szekeres T: Effects of heavy water (D2O) on human pancreatic
tumor cells. Anticancer Res. 25:3407–3411. 2005.PubMed/NCBI
|
|
12
|
Wang H, Zhu B, He Z, Fu H, Dai Z, Huang G,
Li B, Qin D, Zhang X, Tian L, et al: Deuterium-depleted water (DDW)
inhibits the proliferation and migration of nasopharyngeal
carcinoma cells in vitro. Biomed Pharmacother. 67:489–496. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bu H, Wedel S, Cavinato M and Jansen-Dürr
P: MicroRNA regulation of oxidative stress-induced cellular
senescence. Oxid Med Cell Longev. 2017:23986962017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Braicu C, Cojocneanu-Petric R, Chira S,
Truta A, Floares A, Petrut B, Achimas-Cadariu P and Berindan-Neagoe
I: Clinical and pathological implications of miRNA in bladder
cancer. Int J Nanomedicine. 10:791–800. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Irimie AI, Sonea L, Jurj A, Mehterov N,
Zimta AA, Budisan L, Braicu C and Berindan-Neagoe I: Future trends
and emerging issues for nanodelivery systems in oral and
oropharyngeal cancer. Int J Nanomedicine. 12:4593–4606. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Braicu C, Tomuleasa C, Monroig P, Cucuianu
A, Berindan-Neagoe I and Calin GA: Exosomes as divine messengers:
Are they the Hermes of modern molecular oncology? Cell Death
Differ. 22:34–45. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ling H, Pickard K, Ivan C, Isella C, Ikuo
M, Mitter R, Spizzo R, Bullock M, Braicu C, Pileczki V, et al: The
clinical and biological significance of MIR-224 expression in
colorectal cancer metastasis. Gut. 65:977–989. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Braicu C, Calin GA and Berindan-Neagoe I:
MicroRNAs and cancer therapy-from bystanders to major players. Curr
Med Chem. 20:3561–3573. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Geretto M, Pulliero A, Rosano C, Zhabayeva
D, Bersimbaev R and Izzotti A: Resistance to cancer
chemotherapeutic drugs is determined by pivotal microRNA
regulators. Am J Cancer Res. 7:1350–1371. 2017.PubMed/NCBI
|
|
20
|
Ramalingam S, Subramaniam D and Anant S:
Manipulating miRNA expression: A novel approach for colon cancer
prevention and chemotherapy. Curr Pharmacol Rep. 1:141–153. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Taranu I, Braicu C, Marin DE, Pistol GC,
Motiu M, Balacescu L, Beridan Neagoe I and Burlacu R: Exposure to
zearalenone mycotoxin alters in vitro porcine intestinal epithelial
cells by differential gene expression. Toxicol Lett. 232:310–325.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Braicu C, Cojocneanu-Petric R, Jurj A,
Gulei D, Taranu I, Gras AM, Marin DE and Berindan-Neagoe I:
Microarray based gene expression analysis of Sus Scrofa duodenum
exposed to zearalenone: Significance to human health. BMC Genomics.
17:6462016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Pistol GC, Braicu C, Motiu M, Gras MA,
Marin DE, Stancu M, Calin L, Israel-Roming F, Berindan-Neagoe I and
Taranu I: Zearalenone mycotoxin affects immune mediators, MAPK
signalling molecules, nuclear receptors and genome-wide gene
expression in pig spleen. PLoS One. 10:e01275032015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Irimie AI, Braicu C, Pileczki V, Petrushev
B, Soritau O, Campian RS and Berindan-Neagoe I: Knocking down of
p53 triggers apoptosis and autophagy, concomitantly with inhibition
of migration on SSC-4 oral squamous carcinoma cells. Mol Cell
Biochem. 419:75–82. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Braicu C, Pileczki V, Irimie A and
Berindan-Neagoe I: p53siRNA therapy reduces cell proliferation,
migration and induces apoptosis in triple negative breast cancer
cells. Mol Cell Biochem. 381:61–68. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Pileczki V, Braicu C, Gherman CD and
Berindan-Neagoe I: TNF-α gene knockout in triple negative breast
cancer cell line induces apoptosis. Int J Mol Sci. 14:411–420.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Piechota M, Sunderland P, Wysocka A,
Nalberczak M, Sliwinska MA, Radwanska K and Sikora E: Is
senescence-associated β-galactosidase a marker of neuronal
senescence? Oncotarget. 7:81099–81109. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Krämer A, Green J, Pollard J Jr and
Tugendreich S: Causal analysis approaches in ingenuity pathway
analysis. Bioinformatics. 30:523–530. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Carrato A: Adjuvant treatment of
colorectal cancer. Gastrointest Cancer Res. 2 4 Suppl:S42–S46.
2008.PubMed/NCBI
|
|
30
|
Berindan-Neagoe I, Braicu C, Pileczki V,
Cojocneanu Petric R, Miron N, Balacescu O, Iancu D and Ciuleanu T:
5-Fluorouracil potentiates the anti-cancer effect of oxaliplatin on
Colo320 colorectal adenocarcinoma cells. J Gastrointestin Liver
Dis. 22:37–43. 2013.PubMed/NCBI
|
|
31
|
Yoshikawa R, Kusunoki M, Yanagi H, Noda M,
Furuyama JI, Yamamura T and Hashimoto-Tamaoki T: Dual antitumor
effects of 5-fluorouracil on the cell cycle in colorectal carcinoma
cells: A novel target mechanism concept for pharmacokinetic
modulating chemotherapy. Cancer Res. 61:1029–1037. 2001.PubMed/NCBI
|
|
32
|
Braicu C, Tudoran O, Balacescu L, Catana
C, Neagoe E, Berindan-Neagoe I and Ionescu C: The significance of
PDGF expression in serum of colorectal carcinoma
patients-correlation with Duke's classification. Can PDGF become a
potential biomarker? Chirurgia (Bucur). 108:849–854. 2013.
|
|
33
|
Braicu C, Catana C, Calin GA and
Berindan-Neagoe I: NCRNA combined therapy as future treatment
option for cancer. Curr Pharm Des. 20:6565–6574. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Benson AB III, Venook AP, Bekaii-Saab T,
Chan E, Chen YJ, Cooper HS, Engstrom PF, Enzinger PC, Fenton MJ,
Fuchs CS, et al: Colon cancer, version 3.2014. J Natl Compr Canc
Netw. 12:1028–1059. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Campisi J: Aging, cellular senescence, and
cancer. Annu Rev Physiol. 75:685–705. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Cerella C, Grandjenette C, Dicato M and
Diederich M: Roles of apoptosis and cellular senescence in cancer
and aging. Curr Drug Targets. 17:405–415. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Roninson IB: Tumor cell senescence in
cancer treatment. Cancer Res. 63:2705–2715. 2003.PubMed/NCBI
|
|
38
|
Ewald JA, Desotelle JA, Wilding G and
Jarrard DF: Therapy-induced senescence in cancer. J Natl Cancer
Inst. 102:1536–1546. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhao Y, Wu D, Fei C, Guo J, Gu S, Zhu Y,
Xu F, Zhang Z, Wu L, Li X and Chang C: Down-regulation of Dicer1
promotes cellular senescence and decreases the differentiation and
stem cell-supporting capacities of mesenchymal stromal cells in
patients with myelodysplastic syndrome. Haematologica. 100:194–204.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Gorospe M and Abdelmohsen K:
MicroRegulators come of age in senescence. Trends Genet.
27:233–241. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Gibbings D, Mostowy S, Jay F, Schwab Y,
Cossart P and Voinnet O: Selective autophagy degrades DICER and
AGO2 and regulates miRNA activity. Nat Cell Biol. 14:1314–1321.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Bian XJ, Zhang GM, Gu CY, Cai Y, Wang CF,
Shen YJ, Zhu Y, Zhang HL, Dai B and Ye DW: Down-regulation of Dicer
and Ago2 is associated with cell proliferation and apoptosis in
prostate cancer. Tumour Biol. 35:11571–11578. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Prodromaki E, Korpetinou A, Giannopoulou
E, Vlotinou E, Chatziathanasiadou Μ, Papachristou NI, Scopa CD,
Papadaki H, Kalofonos HP and Papachristou DJ: Expression of the
microRNA regulators Drosha, Dicer and Ago2 in non-small cell lung
carcinomas. Cell Oncol (Dordr). 38:307–317. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Gibbings D, Mostowy S and Voinnet O:
Autophagy selectively regulates miRNA homeostasis. Autophagy.
9:781–783. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Grootaert MO, da Costa Martins PA, Bitsch
N, Pintelon I, De Meyer GR, Martinet W and Schrijvers DM: Defective
autophagy in vascular smooth muscle cells accelerates senescence
and promotes neointima formation and atherogenesis. Autophagy.
11:2014–2032. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Hubackova S, Krejcikova K, Bartek J and
Hodny Z: IL1- and TGFβ-Nox4 signaling, oxidative stress and DNA
damage response are shared features of replicative,
oncogene-induced, and drug-induced paracrine ‘bystander
senescence’. Aging (Albany NY). 4:932–951. 2012. View Article : Google Scholar : PubMed/NCBI
|
